Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR

Anne‐Mieke Vandamme; Sonia Van Dooren; Wessel Kok; Patrick Goubau; Katrien Fransen; Tim Kievits; Jean-Claude Schmit; De Clercq Erik; Jan Desmyter

doi:10.1016/0166-0934(94)00151-6

Related publications

Article1995

QUANTIFICATION OF HIV-1 RNA IN PLASMA USING THE NASBA(R) AMPLIFICATION SYSTEM COMPARED TO AN IN-HOUSE QUANTITATIVE RNA-PCR AND THE AMPLICOR(R) HIV MONITOR TEST

Anne‐Mieke Vandamme, JC Schmit, S Vandooren, Kristel Van Laethem, E. Gobbers, Wessel Kok, Nina Albrecht, R. Huygen, Jan Desmyter, De Clercq Erik

Article1996

Quantification of HIV-1 RNA in Plasma: Comparable Results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV Monitor Test

Anne‐Mieke Vandamme, Jean‐Claude Schmit, Sonia Van Dooren, Kristel Van Laethem, E. Gobbers, Wessel Kok, Patrick Goubau, Myriam Witvrouw, Willy Peetermans, De Clercq Erik, Jan Desmyter

Article1998

Selective PCR for the detection of HIV-1 drug resistance mutations in the follow-up of HIV-1 infected patients

Kristel Van Laethem, Kristien Van Vaerenbergh, JC Schmit, De Vroey, Rob Schuurman, S Sprecher, P Hermans, De Clercq Erik, Jan Desmyter, Anne‐Mieke Vandamme

Article1998

Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutations

Ilse Vanderlinden, Theresa Puig, R. Rossau, Jan Desmyter, De Clercq Erik, Bonaventura Clotet, Anne‐Mieke Vandamme, Jean‐Claude Schmit, Lı́dia Ruiz, Lieven Stuyver, Kristel Van Laethem

Article2025

Analysis of PRRSV ORF5 lung and serum samples reveals higher rtPCR Ct values in vaccine-like strains compared to wild-type strains

Rahat Naseer, Michael Zeller, Phillip C. Gauger, Giovani Trevisan